COMMUNIQUÉS West-GlobeNewswire

Elion Therapeutics Expands Pipeline with Exclusive Global License to Inhaled Antifungal for Immunocompromised Patients
14/10/2026
- Phase 2-Ready EL777 Complements Company’s Turletricin Program Focused on Early Antifungal Treatment - Prophylaxis Is Critical for Cancer and Transplant Patients at High Risk of Invasive Fungal Infections BOSTON, Oct. [...]
Parabilis Medicines Initiates Dose-Ranging Clinical Study of Zolucatetide in Familial Adenomatous Polyposis
14/10/2026
New dose-ranging cohort in FAP builds on compelling early clinical evidence observed with zolucatetide in patients with FAP and concomitant desmoid tumors Zolucatetide directly inhibits β-catenin:TCF, targeting the APC- [...]
Axogen, Inc. to Report Third Quarter 2026 Financial Results on October 28, 2026
14/10/2026
ALACHUA, Fla. and TAMPA, Fla., Oct. 14, 2026 (GLOBE NEWSWIRE) -- Axogen, Inc. (Nasdaq: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function, [...]
Eton Pharmaceuticals and Aquestive Therapeutics Announce Exclusive U.S. Licensing Agreement for LIBERVANT® (diazepam) Buccal Film
14/10/2026
Differentiated, portable buccal film would offer patients and caregivers an alternative to existing nasal and rectal seizure rescue treatments, a market opportunity that exceeds $450 million annually in the U.S. Patient [...]
Ocugen and Roots Pharmaceutical Complete License Agreement for OCU400 Modifier Gene Therapy for Retinitis Pigmentosa in the Middle East and North Africa
14/10/2026
Establishes strategic commercial reach across the Middle East and North Africa, advancing Ocugen’s goal of enabling global patient access to potentially transformational gene therapies Expands access to a potential one- [...]
Quoin Pharmaceuticals Announces European Medicines Agency (EMA) Grants Orphan Drug Designation for QRX003 for the Treatment of Peeling Skin Syndrome
14/10/2026
– Company on track to initiate first-ever formal clinical trial in Peeling Skin Syndrome before year end – Orphan Drug designation milestone provides 10 years of market exclusivity for Peeling Skin Syndrome in Europe [...]
Rakovina Therapeutics Secures Exclusivity on Optimized kt-5000 Lead Profile from Variational AI
14/10/2026
Agreement provides Rakovina exclusive access to its optimized kt-5000 target profile and extends AI-powered lead optimization through year-end at no additional cost VANCOUVER, British Columbia, Oct. 14, 2026 (GLOBE [...]
CDT Highlights Sarborg's Solid-Form Patent Filing on a First-in-Class Respiratory Asset
14/10/2026
NAPLES, Fla. and CAMBRIDGE, United Kingdom, Oct. 14, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) ("CDT" or the "Company") today notes the announcement from Sarborg Limited regarding intellectual property [...]
MaxCyte Reports Preliminary Third Quarter 2026 Revenue and Raises Full Year 2026 Revenue Guidance
14/10/2026
MaxCyte will host its third quarter 2026 earnings conference call on November 10, 2026 ROCKVILLE, Md., Oct. 14, 2026 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT), a leading cell-engineering company providing [...]
BillionToOne to Report Third Quarter 2026 Financial Results on November 4, 2026
14/10/2026
MENLO PARK, Calif., Oct. 14, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, [...]
Century Therapeutics to Attend 2026 Jefferies Global Healthcare Conference in London
14/10/2026
PHILADELPHIA, Oct. 14, 2026 (GLOBE NEWSWIRE) -- Century Therapeutics, Inc. (‘Century’, NASDAQ: IPSC), a biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies for type 1 diabetes ( [...]
Tvardi Therapeutics to Participate in Chardan’s 10th Annual Healthcare Conference
14/10/2026
HOUSTON, Oct. 14, 2026 (GLOBE NEWSWIRE) -- Tvardi Therapeutics, Inc. (“Tvardi” or the “Company”) (NASDAQ: TVRD), a clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule [...]
CAMP4 to Participate in Chardan’s 10th Annual Healthcare Conference
14/10/2026
WATERTOWN, Mass., Oct. 14, 2026 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation (“CAMP4”) (Nasdaq: CAMP), a clinical-stage biopharmaceutical company developing a pipeline of regulatory RNA-targeting therapeutics [...]
The MUHC Foundation launches the Women’s Health Circle to accelerate progress in women’s health
14/10/2026
A new philanthropic movement is bringing together 500 women to advance research and care in women’s health, building on strong early support and six transformative projects already underway MONTREAL, Oct. 14, 2026 ( [...]
La Fondation du CUSM lance le Cercle pour la santé des femmes afin d’accélérer les progrès en santé des femmes
14/10/2026
Un nouveau mouvement philanthropique vise à réunir 500 femmes pour faire avancer la recherche et les soins en santé des femmes, en s’appuyant sur un premier appui financier important et six projets porteurs déjà en [...]
Jushi Holdings Inc. to Report Third Quarter 2026 Financial Results on October 28, 2026
14/10/2026
BOCA RATON, Fla., Oct. 14, 2026 (GLOBE NEWSWIRE) -- Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH ) (OTCQX: JUSH ) , a vertically integrated, multi-state cannabis operator, announced that it expects to [...]
PRG Partners with Devsinc to Build the Digital Foundation for Scalable Growth with Microsoft Dynamics 365
14/10/2026
Multi-phase transformation unifies sales, service, finance, and client experience on a single enterprise platform across PRG and its family of companies DOWNERS GROVE, Ill., Oct. 14, 2026 (GLOBE NEWSWIRE) -- Physicians [...]
Alignment Healthcare to Announce Third Quarter 2026 Financial Results and Host Conference Call Thursday, Oct. 29, 2026
14/10/2026
ORANGE, Calif., Oct. 14, 2026 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), will release its third quarter 2026 financial results on Thursday, Oct. 29, 2026, after market close. Following the release, [...]
Globus Medical to Showcase SCRIPT™ Patient-Specific Implants and New XLIF™ Prone Procedural Solution at NASS 2026
14/10/2026
New Innovations Designed to Advance Patient-Specific Planning and Connected Surgical Workflows AUDUBON, Pa., Oct. 14, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology [...]

Pages